FI884983A - Menetelmä terapeuttisesti käyttökelpoisten LL-E33288 kompleksi-disulfidianalogien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten LL-E33288 kompleksi-disulfidianalogien valmistamiseksi Download PDF

Info

Publication number
FI884983A
FI884983A FI884983A FI884983A FI884983A FI 884983 A FI884983 A FI 884983A FI 884983 A FI884983 A FI 884983A FI 884983 A FI884983 A FI 884983A FI 884983 A FI884983 A FI 884983A
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
complex disulfide
disulfide analogs
analogs
Prior art date
Application number
FI884983A
Other languages
English (en)
Swedish (sv)
Other versions
FI884983A0 (fi
FI91262B (fi
FI91262C (fi
Inventor
William James Mcgahren
Martin Leon Sassiver
George A Ellestad
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI884983A0 publication Critical patent/FI884983A0/fi
Publication of FI884983A publication Critical patent/FI884983A/fi
Publication of FI91262B publication Critical patent/FI91262B/fi
Application granted granted Critical
Publication of FI91262C publication Critical patent/FI91262C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI884983A 1987-10-30 1988-10-28 Menetelmä terapeuttisesti käyttökelpoisten LL-E33288 kompleksi-disulfidianalogien valmistamiseksi FI91262C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11494087A 1987-10-30 1987-10-30
US11494087 1987-10-30

Publications (4)

Publication Number Publication Date
FI884983A0 FI884983A0 (fi) 1988-10-28
FI884983A true FI884983A (fi) 1989-05-01
FI91262B FI91262B (fi) 1994-02-28
FI91262C FI91262C (fi) 1994-06-10

Family

ID=22358378

Family Applications (2)

Application Number Title Priority Date Filing Date
FI884984A FI95204C (fi) 1987-10-30 1988-10-28 Menetelmä metyylitritioyhdisteiden kohdennettujen johdannaisten valmistamiseksi
FI884983A FI91262C (fi) 1987-10-30 1988-10-28 Menetelmä terapeuttisesti käyttökelpoisten LL-E33288 kompleksi-disulfidianalogien valmistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI884984A FI95204C (fi) 1987-10-30 1988-10-28 Menetelmä metyylitritioyhdisteiden kohdennettujen johdannaisten valmistamiseksi

Country Status (19)

Country Link
EP (2) EP0313874B1 (fi)
JP (2) JP2820256B2 (fi)
KR (2) KR0133130B1 (fi)
AR (1) AR246083A1 (fi)
AT (2) ATE112172T1 (fi)
AU (2) AU612714B2 (fi)
BR (1) BR1100939A (fi)
CA (1) CA1321582C (fi)
DE (2) DE3889063T2 (fi)
DK (2) DK602488A (fi)
ES (2) ES2061586T3 (fi)
FI (2) FI95204C (fi)
HK (2) HK131897A (fi)
IE (2) IE65053B1 (fi)
IL (2) IL87947A (fi)
NO (2) NO176480C (fi)
NZ (2) NZ226727A (fi)
PT (2) PT88882B (fi)
ZA (2) ZA888123B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
IL115770A (en) * 1989-04-14 1999-03-12 American Cyanamid Co Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
PT2261335T (pt) 1998-11-27 2017-09-08 Ucb Pharma Sa Composições e métodos para aumentar a mineralização óssea
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
MEP2808A (xx) 2003-06-16 2010-02-10 Celltech R & D Inc Antitijela specifična za sklerositin i metode za povećanje mineralizacije kostiju
US8841092B2 (en) * 2006-08-30 2014-09-23 Wisconsin Alumni Research Foundation Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
KR100979928B1 (ko) * 2008-07-16 2010-09-03 한주학 수직축형 부력풍차
SI3066074T1 (sl) * 2013-11-04 2020-03-31 Pfizer Inc. Intermediati in postopki za sintetizacijo derivatov kaliheamicina
EP3573995A1 (en) * 2017-01-24 2019-12-04 Pfizer Inc. Calicheamicin derivatives and antibody drug conjugates thereof
EP3924387A2 (en) * 2019-02-15 2021-12-22 University Of Southern California Lym-1 and lym-2 antibody compositions and improved car constructs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
DE3175151D1 (en) * 1980-05-21 1986-09-25 Teijin Ltd Reactive polymer and process for the preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
DE3588213T2 (de) * 1984-11-16 1999-09-30 American Cyanamid Co Antitumorale Antibiotika (Komplex LL-E-33288)
EP0330874A3 (en) * 1988-02-29 1989-10-18 American Cyanamid Company Antibacterial and antitumor agents LL-E33288 epsilon-I and LL-E33288-epsilonBr, with processes and intermediates for producing said agents
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2

Also Published As

Publication number Publication date
HK131897A (en) 1997-10-03
NO176480C (no) 1995-04-12
EP0313874A3 (en) 1990-05-09
IE883261L (en) 1989-04-30
AU2449488A (en) 1989-05-04
NO176480B (no) 1995-01-02
FI884983A0 (fi) 1988-10-28
JP2720933B2 (ja) 1998-03-04
NO884834D0 (no) 1988-10-28
NO884833D0 (no) 1988-10-28
FI91262B (fi) 1994-02-28
KR970011385B1 (ko) 1997-07-10
DK602488D0 (da) 1988-10-28
ATE104309T1 (de) 1994-04-15
JP2820256B2 (ja) 1998-11-05
NO884834L (no) 1989-05-02
NO173506C (no) 1993-12-22
ZA888127B (en) 1989-07-26
DE3889063T2 (de) 1994-12-01
ATE112172T1 (de) 1994-10-15
IL87946A0 (en) 1989-03-31
DE3851682T2 (de) 1995-05-04
AR246083A1 (es) 1994-03-30
PT88882B (pt) 1993-01-29
KR890006245A (ko) 1989-06-12
DK602588A (da) 1989-05-01
IL87947A (en) 1995-05-26
FI884984A0 (fi) 1988-10-28
IE883262L (en) 1989-04-30
DK602588D0 (da) 1988-10-28
IL87947A0 (en) 1989-03-31
CA1321582C (en) 1993-08-24
IL87946A (en) 1995-06-29
AU612714B2 (en) 1991-07-18
FI95204B (fi) 1995-09-29
HK131997A (en) 1997-10-03
JPH01193282A (ja) 1989-08-03
DE3889063D1 (de) 1994-05-19
EP0313873B1 (en) 1994-09-28
DK174739B1 (da) 2003-10-13
AU618763B2 (en) 1992-01-09
AU2448988A (en) 1989-05-04
NO173506B (no) 1993-09-13
EP0313874A2 (en) 1989-05-03
NZ226726A (en) 1991-08-27
PT88881B (pt) 1993-01-29
NZ226727A (en) 1991-12-23
IE65989B1 (en) 1995-11-29
FI884984A (fi) 1989-05-01
ZA888123B (en) 1989-07-26
EP0313874B1 (en) 1994-04-13
ES2061586T3 (es) 1994-12-16
DE3851682D1 (de) 1994-11-03
ES2059464T3 (es) 1994-11-16
DK602488A (da) 1989-05-01
FI95204C (fi) 1996-01-10
EP0313873A1 (en) 1989-05-03
KR0133130B1 (ko) 1998-04-17
KR890006244A (ko) 1989-06-12
FI91262C (fi) 1994-06-10
BR1100939A (pt) 1999-08-31
IE65053B1 (en) 1995-10-04
JPH0296599A (ja) 1990-04-09
NO884833L (no) 1989-05-02

Similar Documents

Publication Publication Date Title
FI92388B (fi) Menetelmä karbasykliinianalogien terapeuttisesti käyttökelpoisten syklodekstriiniklatraattien valmistamiseksi
PT86875A (pt) Process for the preparation of phenylcarbamate
MX12213A (es) Metodo de preparacion de dihidrato de azitromicina cristalino
PT86600A (pt) Process for the preparation of anticoagulant peptides
IS1667B (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkumbis-aza-bísýklískum efnasamböndum
IT1202447B (it) Procedimento per la produzione di benzina
PT86800A (pt) Process for the preparation of erythromycin derivatives
PT87191A (pt) Process for the preparation of nucleosides
FI91262B (fi) Menetelmä terapeuttisesti käyttökelpoisten LL-E33288 kompleksi-disulfidianalogien valmistamiseksi
FI872517A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten makrolidiyhdisteiden valmistamiseksi
PT87698A (pt) Procede de preparation de derives de n-phenylpyrazole
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI883997A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI895393A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten alkyylisubstituoitujen 2-alkyyliamiinibentsopyran-6-olien valmistamiseksi
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
PT87854A (pt) Process for the preparation of thio-urea derivatives
FI92064C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-bentsopyranyylilaktaamien valmistamiseksi
IT8867394A0 (it) Procedimento per la preparazionedi idrocarburi
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
PT87687A (pt) Process for the preparation of 9 (11)-dihydro steroids
FI884473A (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
PT86960A (pt) Process for the preparation of immunoglobulin conjugates
ES2022952B3 (es) Proceso para la preparacion de naftacenos

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: WYETH HOLDINGS CORPORATION

MA Patent expired